Baird Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Sell |
2,147
-421
| -16% | -$63.9K | ﹤0.01% | 1556 |
|
|
2025
Q1 | $387K | Sell |
2,568
-24
| -0.9% | -$3.61K | ﹤0.01% | 1468 |
|
|
2024
Q4 | $478K | Sell |
2,592
-5,494
| -68% | -$1.01M | ﹤0.01% | 1396 |
|
|
2024
Q3 | $1.59M | Sell |
8,086
-28
| -0.3% | -$5.52K | ﹤0.01% | 1030 |
|
|
2024
Q2 | $1.68M | Buy |
8,114
+2,594
| +47% | +$536K | ﹤0.01% | 1013 |
|
|
2024
Q1 | $1.5M | Buy |
5,520
+3,247
| +143% | +$880K | ﹤0.01% | 1035 |
|
|
2023
Q4 | $537K | Buy |
2,273
+197
| +9% | +$46.6K | ﹤0.01% | 1327 |
|
|
2023
Q3 | $407K | Buy |
+2,076
| New | +$407K | ﹤0.01% | 1405 |
|
|
2022
Q4 | – | Sell |
-150,586
| Closed | -$29.6M | – | 1697 |
|
|
2022
Q3 | $29.6M | Sell |
150,586
-17,313
| -10% | -$3.41M | 0.09% | 228 |
|
|
2022
Q2 | $35.9M | Buy |
167,899
+56,069
| +50% | +$12M | 0.1% | 217 |
|
|
2022
Q1 | $31.8M | Buy |
111,830
+110,954
| +12,666% | +$31.5M | 0.08% | 242 |
|
|
2021
Q4 | $330K | Sell |
876
-137
| -14% | -$51.6K | ﹤0.01% | 1634 |
|
|
2021
Q3 | $418K | Buy |
+1,013
| New | +$418K | ﹤0.01% | 1540 |
|